Haoxi Health Technology Limited

 

June 18, 2024

 

Via EDGAR

 

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

 

Attention:

Nicholas Nalbantian

  

Re:	Haoxi Health Technology Limited
	Registration Statement on Form F-1, as amended
	Initially Filed on June 13, 2024
	File No. 333-280174

 

Dear Mr. Nalbantian:

 

On June 13, 2024, Haoxi Health Technology Limited (the “Company”) requested acceleration of the effective date of the above referenced Registration Statement so that it would become effective at 4:30 p.m. ET on June 17, 2024, or as soon as thereafter as practicable, which date the Company subsequently requested be extended to 4:30 p.m. ET on June 18, 2024. We hereby withdraw our request for acceleration of effectiveness.

 

	Very truly yours,
	Haoxi Health Technology Limited
	By:	/s/ Fan Zhen
		Name:	Fan Zhen
		Title:	Chief Executive Officer, Director